What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
This piece breaks down why Total Market Return 2024 matters, highlighting drivers, risks, and practical steps to align holdings with your goals.
28,491 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
After a sharp drop in Robinhood stock, investors wonder what comes next. This article breaks down scenarios, real-wor...
Lawmakers’ stock trades tied to bills they’re about to vote on have renewed debate over whether current rules protect...
Intel stock popped today as optimism about AI demand and data-center upgrades fed investor enthusiasm. This article b...
Three ETFs are positioning investors for the next leg of AI-driven growth, offering diversified exposure as markets r...
This article breaks down the key themes from the semiconductor 2025 earnings call, highlighting demand cycles, margin...
Meta Platforms rides a pivotal thesis: AI compute demand is real, scarce, and driving a company-wide pivot to data in...
BNB Chain invites builders, investors, and institutional leaders to a day of demos and expert panels at PAMM during C...
Amazon executed a $25 billion debt sale that drew heavy demand and extended its growth funding runway. Here are three...
MP Materials jumped about 30% in a month, signaling growing investor interest in U.S. rare-earth supply. This article...
The AFL-CIO argues the Senate version of the CLARITY Act could channel digital assets into retirement accounts with w...
A news-driven swing in Ondas stock sparked investor curiosity. This guide breaks down the catalysts, what it means fo...